Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Cilostazol in Prevention of Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

NCT05298696 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05298696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Cilostazol in Prevention of Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Lead sponsor
Mansoura University
Phase
Phase 1/2
Overall status
Completed
Start date
March 28, 2022
Completion date
December 30, 2022
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, peripheral neuropathy